Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 668

  • Showing results for sequencing circulating tumor dna. Your search for seqeuncing circulating tumor dna retrieved no results.
1.

CIRCULATING TUMOR DNA ANALYSIS ENABLES MOLECULAR CHARACTERIZATION OF PEDIATRIC RENAL TUMORS AT DIAGNOSIS.

Jiménez I, Chicard M, Colmet-Daage L, Clément N, Danzon A, Lapouble E, Pierron G, Bohec M, Baulande S, Berrebi D, Fréneaux P, Coulomb A, Galmiche-Rolland L, Sarnacki S, Audry G, Philippe-Chomette P, Brisse HJ, Doz F, Michon J, Delattre O, Schleiermacher G.

Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31620. [Epub ahead of print]

PMID:
29923174
2.

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.

Yang YC, Wang D, Jin L, Yao HW, Zhang JH, Wang J, Zhao XM, Shen CY, Chen W, Wang XL, Shi R, Chen SY, Zhang ZT.

Biosci Rep. 2018 Jun 18. pii: BSR20180322. doi: 10.1042/BSR20180322. [Epub ahead of print]

PMID:
29914973
3.

Gene’s expression profile for breast cancer, clinical and therapeutic approach

Vargas-Aguilar VM, Arroyo-Alvarez K.

Rev Med Inst Mex Seguro Soc. 2018 Mar-Apr;56(2):180-185. Spanish.

PMID:
29906029
4.

Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers With or Without Liver Metastases.

Gai W, Ji L, Lam WKJ, Sun K, Jiang P, Chan AWH, Wong J, Lai PBS, Ng SSM, Ma BBY, Wong GLH, Wong VWS, Chan HLY, Chiu RWK, Lo YMD, Chan KCA.

Clin Chem. 2018 Jun 14. pii: clinchem.2018.290304. doi: 10.1373/clinchem.2018.290304. [Epub ahead of print]

PMID:
29903871
5.

Harnessing Tumor Evolution to Circumvent Resistance.

Pogrebniak KL, Curtis C.

Trends Genet. 2018 Jun 11. pii: S0168-9525(18)30092-1. doi: 10.1016/j.tig.2018.05.007. [Epub ahead of print] Review.

PMID:
29903534
6.

Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer.

Kim TW, Peeters M, Thomas AL, Gibbs P, Hool K, Zhang J, Ang A, Bach BA, Price T.

Clin Cancer Res. 2018 Jun 13. pii: clincanres.3377.2017. doi: 10.1158/1078-0432.CCR-17-3377. [Epub ahead of print]

PMID:
29898991
7.

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.

Yamazaki K, Taniguchi H, Yoshino T, Akagi K, Ishida H, Ebi H, Nakatani K, Muro K, Yatabe Y, Yamaguchi K, Tsuchihara K.

Cancer Sci. 2018 Jun;109(6):2074-2079. doi: 10.1111/cas.13617.

8.

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease.

Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA.

J Neuropathol Exp Neurol. 2018 Jul 1;77(7):628-635. doi: 10.1093/jnen/nly046.

PMID:
29873738
9.

The potential of liquid biopsies for the early detection of cancer.

Heitzer E, Perakis S, Geigl JB, Speicher MR.

NPJ Precis Oncol. 2017 Oct 17;1(1):36. doi: 10.1038/s41698-017-0039-5. eCollection 2017. Review.

10.

Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology.

Renier C, Pao E, Che J, Liu HE, Lemaire CA, Matsumoto M, Triboulet M, Srivinas S, Jeffrey SS, Rettig M, Kulkarni RP, Di Carlo D, Sollier-Christen E.

NPJ Precis Oncol. 2017 May 8;1(1):15. doi: 10.1038/s41698-017-0015-0. eCollection 2017.

11.

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.

Ikeda S, Schwaederle M, Mohindra M, Fontes Jardim DL, Kurzrock R.

J Hematol Oncol. 2018 Jun 4;11(1):76. doi: 10.1186/s13045-018-0610-8.

12.

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.

Chen S, El-Heliebi A, Schmid J, Kashofer K, Czyż ZT, Polzer BM, Pantel K, Kroneis T, Sedlmayr P.

J Vis Exp. 2018 May 15;(135). doi: 10.3791/56394.

PMID:
29863657
13.

Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients.

Xie F, Zhang Y, Mao X, Zheng X, Han-Zhang H, Ye J, Zhao R, Zhang X, Sun J.

Lung Cancer. 2018 Jul;121:54-60. doi: 10.1016/j.lungcan.2018.05.002. Epub 2018 May 5.

PMID:
29858028
14.

A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories.

Kim Y, Shin S, Lee KA.

Biomed Res Int. 2018 May 8;2018:7392419. doi: 10.1155/2018/7392419. eCollection 2018.

15.

Characterizing the Cancer Genome in Blood.

Dawson SJ.

Cold Spring Harb Perspect Med. 2018 May 29. pii: a026880. doi: 10.1101/cshperspect.a026880. [Epub ahead of print]

PMID:
29844219
16.

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.

Weerts MJA, Timmermans EC, van de Stolpe A, Vossen RHAM, Anvar SY, Foekens JA, Sleijfer S, Martens JWM.

Neoplasia. 2018 May 26;20(7):687-696. doi: 10.1016/j.neo.2018.05.003. [Epub ahead of print]

17.
18.

A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.

Molparia B, Oliveira G, Wagner JL, Spencer EG, Torkamani A.

PLoS One. 2018 May 23;13(5):e0196826. doi: 10.1371/journal.pone.0196826. eCollection 2018.

19.

Precision Medicine in Hormone Receptor-Positive Breast Cancer.

Nasrazadani A, Thomas RA, Oesterreich S, Lee AV.

Front Oncol. 2018 May 4;8:144. doi: 10.3389/fonc.2018.00144. eCollection 2018. Review.

20.

Comprehensive targeted super-deep next generation sequencing enhances differential diagnosis of solitary pulmonary nodules.

Ye M, Li S, Huang W, Wang C, Liu L, Liu J, Liu J, Pan H, Deng Q, Tang H, Jiang L, Huang W, Chen X, Shao D, Peng Z, Wu R, Zhong J, Wang Z, Zhang X, Kristiansen K, Wang J, Yin Y, Mao M, He J, Liang W.

J Thorac Dis. 2018 Apr;10(Suppl 7):S820-S829. doi: 10.21037/jtd.2018.04.09.

Supplemental Content

Loading ...
Support Center